Wednesday, 23 October 2019

Charles River acquires microbe testing lab

06 November 2013 | News | By BioSpectrum Bureau

Charles River acquires Singapore-based microbiology subcontract test laboratory Brass

Charles River acquires Singapore-based microbiology subcontract test laboratory Brass

Singapore: Charles River has acquired Brass, a Singapore-based microbiology subcontract test laboratory specializing in endotoxin testing, bacterial and fungal identification.

The objective of the acquisition is to accelerate growth of its portfolio of products and services in Asia by providing clients' microbial detection and identification for manufacturing in the biopharmaceutical, medical device and life sciences industries.

Under the acquisition, Brass will be known as Charles River Endotoxin and Microbial Detection Singapore and will add to Charles River's presence in Asia, which includes sites in South Korea, India and China.

This acquisition is Charles River's second for a laboratory business since 2012 and is consistent with the division's bid to expand their microbiological services portfolio.

Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account



Podcast

 

Survey Box

Is Asia-Pacific dominating the global digital transformation in healthcare market?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls